Get Brochure

The Prescribing Information (USPI), also referred to as the package insert or label, is a US FDA-approved product label and a crucial document containing essential information for healthcare professionals to prescribe and monitor the safe use of prescription drugs and biologics in the United States. It is divided into Highlights of Prescribing Information, Table of Contents, and Full Prescribing Information.

What is the importance of US Prescribing Information (USPI) for drug development?

  • Regulatory Compliance: The USPI is a mandatory component of the marketing application for drugs and biologics submitted to the FDA. It ensures that products meet regulatory requirements for safety, efficacy, and quality.
  • Guiding Prescribing Decisions: The USPI serves as the primary source of information for healthcare professionals to make informed decisions about prescribing medications. It helps ensure appropriate use and minimize risks.
  • Facilitating Safe and Effective Use: By providing comprehensive information about a drug's indications, dosing, contraindications, warnings, and adverse reactions, the USPI contributes to the safe and effective use of medications by healthcare professionals.
  • Enabling Pharmacovigilance: The USPI includes important safety information that is crucial for post-marketing surveillance and monitoring of adverse events by the FDA and pharmaceutical companies.

What are some of the challenges associated with a USPI?

  • Compliance with SPL Standards: Ensuring the USPI is formatted according to SPL standards can be challenging, particularly as it must be compatible with various digital platforms and electronic health records (EHRs).
  • Adhering to PLR format: The Patient Labelling Rule (PLR) format requires a specific structure and layout for the USPI, including standardized headings and sections. Maintaining consistency and meeting FDA formatting guidelines can be resource-intensive and complex.
  • Evolving Regulatory Guidelines: The regulatory landscape is continuously changing, with updates to guidelines that govern the content and format of the NCO. Staying compliant with these evolving requirements can be resource-intensive and may necessitate frequent revisions to the document.
  • Boxed Warnings: Deciding when to include or update boxed warnings (black box warnings) is critical to ensuring that severe risks are adequately communicated without causing unnecessary alarm.
  • Communicating Complex Information: Translating complex scientific and medical information into clear, understandable language for healthcare professionals can be challenging. The USPI must convey critical information effectively while avoiding jargon.
  • Dynamic Content: The USPI must be updated regularly to reflect new clinical data, safety information, or changes in the drug’s approved uses. This requires ongoing monitoring and revision to ensure that the prescribing information remains accurate and compliant with the latest FDA regulations.

DDReg’s Capabilities

The medical writing team at DDReg comprises experienced professionals with years of experience in authoring high-quality documents. They are also well-trained in quality checks, reviewing, uploading in SPL standards, and providing assistance throughout the submission process.

How can we help you?
Contact our experts today !